Reply to ‘Emergence of Streptococcus pneumoniae serotype 19A (Spn19A) in the pediatric population in Bogotá, Colombia as the main cause of invasive pneumococcal disease after the introduction of PCV10’
Main Authors: | Javier Nieto Guevara, Patricia Izurieta |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-09-01
|
Series: | Human Vaccines & Immunotherapeutics |
Online Access: | http://dx.doi.org/10.1080/21645515.2020.1784654 |
Similar Items
-
Emergence of Streptococcus pneumoniae serotype 19A (Spn19A) in the pediatric population in Bogotá, Colombia as the main cause of invasive pneumococcal disease after the introduction of PCV10
by: Germán Camacho Moreno, et al.
Published: (2020-09-01) -
Response to: Pneumococcal conjugate vaccines in Latin America: are PCV10 and PCV13 similar in terms of protection against serotype 19A?
by: Javier Nieto Guevara, et al.
Published: (2018-04-01) -
Exploring the evidence behind the comparable impact of the pneumococcal conjugate vaccines PHiD-CV and PCV13 on overall pneumococcal disease
by: Patricia Izurieta, et al.
Published: (2022-01-01) -
Changes in Invasive pneumococcal disease caused by Streptococcus pneumoniae Serotype 1 following introduction of PCV10 and PCV13: findings from the PSERENADE Project
by: Bennett, J, et al.
Published: (2021) -
Changes in Invasive Pneumococcal Disease Caused by <em>Streptococcus pneumoniae</em> Serotype 1 following Introduction of PCV10 and PCV13: Findings from the PSERENADE Project
by: Julia C. Bennett, et al.
Published: (2021-03-01)